Browse studies

Find your next paid study

27,370 recruiting studies available now

A Phase 1 Study of BET Bromodomain Inhibitor ZEN003694 in Combination With the CDK4/6 Inhibitor Abemaciclib in Patients With NUT Carcinoma, Breast Cancer and Other Solid Tumors

This phase I trial tests the safety, side effects, and best dose of ZEN003694 when given together with abemaciclib in treating patients with NUT carcinoma, bre…

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+5 more

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05372640

Phase 1

A Phase 1 Study of Combination Tovorafenib (DAY101) and Rituximab Treatment in Relapsed or Refractory Classical Hairy Cell Leukemia and Phase 2 Randomized Study Comparing Tovorafenib (DAY101) and Rituximab With Cladribine and Rituximab for Front-Line Treatment of Classical Hairy Cell Leukemia

This phase I/II trial tests the safety, side effects, and effectiveness of tovorafenib in combination with rituximab in patients with classical hairy cell leuk…

Hairy Cell LeukemiaRecurrent Hairy Cell LeukemiaRefractory Hairy Cell Leukemia

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT06965114

Phase 1

A Phase 1 Study of the Bromodomain Inhibitor ZEN003694 in Combination With Platinum-based Chemotherapy in Patients With NUT Carcinoma

This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with cisplatin and etoposide or carboplatin and paclitaxel in trea…

Advanced NUT CarcinomaMetastatic NUT CarcinomaUnresectable NUT Carcinoma

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT05019716

Observational

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

This is a pilot randomized, sham-controlled, double-blind, multi-center study evaluating the safety and preliminary effectiveness of the Gen0Bh Transcranial Fo…

Parkinson Disease

Estimated

~$10 – $7,500

Sanmai Technologies PBC dba SanmaiNCT07207122

Phase 3

Multi-Center Clean Air Randomized Controlled Trial in COPD

This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air q…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $6,250

JHSPH Center for Clinical TrialsNCT06376994

Phase 2

Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)

This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…

Acute Respiratory Distress Syndrome (ARDS)ARDSARDS (Acute Respiratory Distress Syndrome)+1 more

Estimated

~$10 – $7,500

PPD Development, LPNCT06701656

Comparison of Continous Glucose Monitor and OGTT as a Screen for Cystic Fibrosis Related Diabetes and Impaired Glucose Tolerance

Cystic Fibrosis (CF) related diabetes (CFRD) is a unique form of diabetes mellitus, different from type 1 diabetes and type 2 diabetes. The diagnosis of CFRD i…

Cystic Fibrosis-related DiabetesCystic Fibrosis

Estimated

~$10 – $750

Medical College of WisconsinNCT06560463

Observational

I CARE (Immunotherapy Cutaneous Adverse Events REsearch) - A Trial With Diverse Cancer Patients to Determine the Impact of SDoH and Side Effects Navigation Program on Treatment Continuation

The purpose of this study is to find out if the navigation program helps participants manage immunotherapy treatment better than usual care. Investigators will…

Kidney CancerBladder CancerBreast Cancer+1 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07646847

SLC6A1-NDD Prospective Longitudinal Natural History Study

The overall objective of this prospective longitudinal natural history study is to collect clinical data to characterize and evaluate the natural course of SLC…

SLC6A1 Neurodevelopmental Disorder (NDD)Developmental and Epileptic Encephalopathies (DEE)

Estimated

~$10 – $1,050

UCB Biopharma SRLNCT07531511

Phase 2

An Open-Label Uncontrolled Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Activity of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

The purpose of this study is to determine the effect of nipocalimab on total serum immunoglobulin G (IgG) in pediatric participants 2 to less than (\<) 18 year…

Myasthenia Gravis

Estimated

~$10 – $8,750

Janssen Research & Development, LLCNCT05265273

The Oxford Risk Factors And Non-Invasive Imaging Study

ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and valida…

Cardiovascular DiseasesCardiovascular Risk Factors

Estimated

~$10 – $750

University of OxfordNCT05169333

Observational

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Conquer-AF is a prospective, multi-center, interventional, non-randomized clinical study that will enroll up to 400 subjects at up to 30 sites across the Unite…

Atrial Fibrillation (AF)Persistent Atrial FibrillationParoxysmal Atrial Fibrillation (PAF)

Estimated

~$10 – $7,500

Medtronic Cardiac Ablation SolutionsNCT07298473